These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11010798)

  • 1. Unilateral temporalis muscle hypertrophy managed with botulinum toxin type A.
    Isaac AM
    Br J Oral Maxillofac Surg; 2000 Oct; 38(5):571-2. PubMed ID: 11010798
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral temporalis hypertrophy.
    Ali K; Sittampalam G; Malik MA
    Int J Oral Maxillofac Surg; 2010 Mar; 39(3):305-7. PubMed ID: 19836926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary.
    De Almeida AR
    Dermatol Surg; 2009 Dec; 35(12):1907. PubMed ID: 20050146
    [No Abstract]   [Full Text] [Related]  

  • 4. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Isaac AM, Moss CE, Whear NM. Unilateral temporalis muscle hypertrophy managed with botulinum toxin type A. Br J Oral Maxillofac Surg 2000; 38: 571-572.
    Clark M; Koppel DA
    Br J Oral Maxillofac Surg; 2001 Dec; 39(6):483. PubMed ID: 11735149
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
    Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M
    Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
    Einecke D
    MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
    [No Abstract]   [Full Text] [Related]  

  • 12. Durability of botulinum toxin injection for axillary hyperhidrosis.
    James R; Phillips D; Collin J
    Br J Surg; 2005 Jul; 92(7):834-5. PubMed ID: 15892160
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
    El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
    Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needle-free anaesthesia prior to botulinum toxin type A injection treatment of palmar and plantar hyperhidrosis.
    Benohanian A
    Br J Dermatol; 2007 Mar; 156(3):593-6. PubMed ID: 17300264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Persistent injury to an ocular motor muscle secondary to injection of botulinum toxin].
    Gómez-Argüelles JM; Sebastián-de la Cruz F
    Rev Neurol; 2008 Mar 1-15; 46(5):318-9. PubMed ID: 18351572
    [No Abstract]   [Full Text] [Related]  

  • 18. How do we get better outcome with botulinum toxin in the treatment of children with spastic hemiplegia?
    Dai AI
    Eura Medicophys; 2007 Jun; 43(2):296-7; author reply 297. PubMed ID: 17589419
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Cartwright R; Cardozo L
    J Urol; 2007 Feb; 177(2):796-7; author reply 797. PubMed ID: 17222687
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal delivery of Clostridium botulinum toxin type A by pulsed current iontophoresis.
    Pacini S; Gulisano M; Punzi T; Ruggiero M
    J Am Acad Dermatol; 2007 Dec; 57(6):1097-9. PubMed ID: 18021859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.